Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders

Advances in functional and structural MR image analysis and implementation as FSL

Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E. J., Johansen-Berg, H., Bannister, P. R., De Luca, M., Drobnjak, I., Flitney, D. E., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.051 · Cited by 13,630 · see citing works

Bipolar Disorder

Yatham, L. N., & Malhi, G. S. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,515 · see citing works

A Bayesian model of shape and appearance for subcortical brain segmentation

Patenaude, B., Smith, S. M., Kennedy, D. N., & Jenkinson, M. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.02.046 · Cited by 2,287 · see citing works

The economic cost of brain disorders in Europe

Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H., & Jönsson, B. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03590.x · Cited by 1,560 · see citing works

Voxel-based morphometry of the human brain: Methods and applications

Mechelli, A., Price, C., Friston, K. J., & Ashburner, J. (2005) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405054038726 · Cited by 928 · see citing works

A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder

McKinnon, M. C., Yucel, K., Nazarov, A., & MacQueen, G. M. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0905 · Cited by 742 · see citing works

Enhancement of Hippocampal Neurogenesis by Lithium

Chen, G., Rajkowska, G., Du, F., Seraji‐Bozorgzad, N., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751729.x · Cited by 601 · see citing works

The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling

Bessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.119 · Cited by 598 · see citing works

A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes

Morey, R. A., Petty, C. M., Xu, Y., Pannu Hayes, J., Wagner, H. R., Lewis, D. V., LaBar, K. S., Styner, M., & McCarthy, G. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.033 · Cited by 540 · see citing works

Neurocognitive deficits and disability in major depressive disorder

Jaeger, J., Berns, S., Uzelac, S., & Davis-Conway, S. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.11.011 · Cited by 484 · see citing works

What causes the hippocampal volume decrease in depression?: Are neurogenesis, glial changes and apoptosis implicated?

Czéh, B., & Lucassen, P. J. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0728-0 · Cited by 419 · see citing works

Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain

Fukumoto, T., Morinobu, S., Okamoto, Y., Kagaya, A., & Yamawaki, S. (2001) · Psychopharmacology · doi:10.1007/s002130100871 · Cited by 377 · see citing works

Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress

Magariños, A. M., Deslandes, A., & McEwen, B. S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00163-6 · Cited by 330 · see citing works

An economic evaluation of manic-depressive illness-1991

Wyatt, R. J., & Henter, I. D. (1995) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00789056 · Cited by 316 · see citing works

Hippocampal Apoptosis in Major Depression Is a Minor Event and Absent from Subareas at Risk for Glucocorticoid Overexposure

Lucassen, P. J., Müller, M. B., Holsboer, F., Bauer, J., Holtrop, A., Wouda, J., Hoogendijk, W. J. G., de Kloet, E. R., & Swaab, D. F. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63988-0 · Cited by 284 · see citing works

Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study

Frodl, T., Jäger, M., Smajstrlova, I., Born, C., Bottlender, R., Palladino, T., Reiser, M., Möller, H.-J., & Meisenzahl, E. M. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0840 · Cited by 279 · see citing works

Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin

Ehrenreich, H., Hinze‐Selch, D., Stawicki, S., Aust, C., Knolle-Veentjer, S., Wilms, S., Heinz, G., Erdag, S., Jahn, H., Degner, D., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001907 · Cited by 260 · see citing works

Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis

Ehrenreich, H., Fischer, B., Norra, C., Schellenberger, F., Stender, N., Stiefel, M., Sirén, A., Paulus, W., Nave, K., Gold, R., et al. (2007) · Brain · doi:10.1093/brain/awm203 · Cited by 236 · see citing works

Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study

Yücel, K., McKinnon, M. C., Taylor, V. H., Macdonald, K., Alda, M., Young, L. T., & MacQUEEN, G. M. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0906-9 · Cited by 214 · see citing works

Remodeling of Hippocampal Spine Synapses in the Rat Learned Helplessness Model of Depression

Hajszán, T., Dow, A. L., Warner‐Schmidt, J. L., Szigeti‐Buck, K., Sallam, N. L., Párducz, Á., Leranth, C., & Duman, R. S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.031 · Cited by 212 · see citing works

Structural changes in hippocampal subfields in major depressive disorder: a high-field magnetic resonance imaging study

Huang, Y., Coupland, N. J., Lebel, R. M., Carter, R., Seres, P., Wilman, A. H., & Malykhin, N. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.005 · Cited by 179 · see citing works

Erythropoietin enhances hippocampal long-term potentiation and memory

Adamcio, B., Sargin, D., Stradomska, A., Medrihan, L., Gertler, C., Theis, F. J., Zhang, M., Müller, M., Hassouna, I. A., Hannke, K., et al. (2008) · BMC Biology · doi:10.1186/1741-7007-6-37 · Cited by 164 · see citing works

Erythropoietin as neuroprotective and neuroregenerative treatment strategy: Comprehensive overview of 12 years of preclinical and clinical research

Sargin, D., Friedrichs, H., El-Kordi, A., & Ehrenreich, H. (2010) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2010.10.005 · Cited by 150 · see citing works

Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview

Dias, V. V., Balanzá‐Martinez, V., Soeiro‐de‐Souza, M. G., Moreno, R. A., Figueira, M. L., Machado‐Vieira, R., & Vieta, E. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01910.x · Cited by 146 · see citing works

Hippocampal volume and total cell numbers in major depressive disorder

Cobb, J. A., Simpson, J., Mahajan, G., Overholser, J. C., Jurjus, G., Dieter, L., Herbst, N. P., May, W., Rajkowska, G., & Stockmeier, C. A. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.020 · Cited by 144 · see citing works

ASsociation of gsk3β polymorphisms with brain structural changes in major depressive disorder

Inkster, B., Nichols, T. E., Saemann, P. G., Auer, D. P., Holsboer, F., Muglia, P., & Matthews, P. M. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.70 · Cited by 127 · see citing works

Influence of Clinical and Neuropsychological Variables on the Psychosocial and Occupational Outcome of Remitted Bipolar Patients

Mur, M., Portella, M. J., Martínez‐Arán, A., Pifarré, J., & Vieta, E. (2009) · Psychopathology · doi:10.1159/000207456 · Cited by 109 · see citing works

Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial

Miskowiak, K. W., Vinberg, M., Christensen, E. M., Bukh, J. D., Harmer, C. J., Ehrenreich, H., & Kessing, L. V. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.335 · Cited by 104 · see citing works

Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder

Miskowiak, K. W., Ehrenreich, H., Christensen, E. M., Kessing, L. V., & Vinberg, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08839 · Cited by 99 · see citing works

Comprehensive morphometry of subcortical grey matter structures in early‐stage Parkinson's disease

Menke, R., Szewczyk‐Królikowski, K., Jbabdi, S., Jenkinson, M., Talbot, K., Mackay, C. E., & Hu, M. (2013) · Human Brain Mapping · doi:10.1002/hbm.22282 · Cited by 97 · see citing works

Subregional hippocampal deformations in major depressive disorder

Cole, J., Toga, A. W., Hojatkashani, C., Thompson, P., Costafreda, S. G., Cleare, A. J., Williams, S. C. R., Bullmore, E. T., Scott, J. L., & Mitterschiffthaler, M. T. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.03.004 · Cited by 94 · see citing works

Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia

Wüstenberg, T., Begemann, M., Bartels, C., Gefeller, O., Stawicki, S., Hinze‐Selch, D., Mohr, A., Falkai, P., Aldenhoff, J., Knauth, M., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.51 · Cited by 93 · see citing works

Autoradiographic localization of glucocorticosteroid and progesterone binding sites in the human post-mortem brain

Sarrieau, A., Dussaillant, M., Javoy-Agid, F., Philibert, D., Agid, Y., & Rostène, W. H. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90300-6 · Cited by 86 · see citing works

Erythropoietin Induction by Electroconvulsive Seizure, Gene Regulation, and Antidepressant-Like Behavioral Effects

Girgenti, M. J., Hunsberger, J. G., Duman, C. H., Sathyanesan, M., Terwilliger, R. Z., & Newton, S. S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.005 · Cited by 79 · see citing works

Role of Integrated 18-F FDG PET/CT in Recurrent Ovarian Cancer

Sironi, S., Messa, C., & Fazio, F. (2005) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405052953010 · Cited by 77 · see citing works

Structural Abnormalities in Bipolar Euthymia: A Multicontrast Molecular Diffusion Imaging Study

Canales-Rodríguez, E. J., Pomarol-Clotet, E., Radua, J., Sarró, S., Alonso-Lana, S., Del Mar Bonnín, C., Goikolea, J. M., Maristany, T., García-Álvarez, R., Vieta, E., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.09.027 · Cited by 72 · see citing works

Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression

Miskowiak, K. W., Vinberg, M., Harmer, C. J., Ehrenreich, H., & Kessing, L. V. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2511-1 · Cited by 70 · see citing works

Cellular abnormalities in depression: evidence from postmortem brain tissue

Stockmeier, C. A., & Rajkowska, G. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.2/cstockmeier · Cited by 67 · see citing works

Hippocampal Shape Deformation in Female Patients with Unremitting Major Depressive Disorder

Tae, W., Kim, S. S., Lee, K. U., Nam, E., Choi, J. W., & Park, J. I. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2367 · Cited by 48 · see citing works

Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania

Frey, B. N., Andreazza, A. C., Rosa, A. R., Martins, M. R., Valvassori, S. S., Réus, G. Z., Hatch, J. P., Quevedo, J., & Kapczinski, F. P. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000205013.59455.09 · Cited by 46 · see citing works

Electroconvulsive stimulations prevent stress-induced morphological changes in the hippocampus

Hageman, I., Nielsen, M., Wörtwein, G., Diemer, N. H., & Jørgensen, M. B. (2008) · Stress · doi:10.1080/10253890701783794 · Cited by 39 · see citing works

Opposite effects of glucocorticoid receptor activation on hippocampal CA1 dendritic complexity in chronically stressed and handled animals

Alfarez, D. N., Karst, H., Velzing, E. H., Joëls, M., & Krugers, H. J. (2007) · Hippocampus · doi:10.1002/hipo.20360 · Cited by 39 · see citing works

Evidence for reduced dentate gyrus and fimbria volume in bipolar II disorder

Elvsåshagen, T., Westlye, L. T., Bøen, E., Hol, P. K., Andersson, S., Andreassen, O. A., Boye, B., & Malt, U. F. (2013) · Bipolar Disorders · doi:10.1111/bdi.12046 · Cited by 34 · see citing works

Erythropoietin attenuates 6-hydroxydopamine-induced apoptosis via glycogen synthase kinase 3β-mediated mitochondrial translocation of Bax in PC12 cells

Ge, X., Zhu, G., Geng, D., Zhang, Z., & Liu, C. (2012) · Neurological Sciences · doi:10.1007/s10072-012-0959-3 · Cited by 23 · see citing works

Comparison of Neurite Outgrowth Induced by Erythropoietin (EPO) and Carbamylated Erythropoietin (CEPO) in Hippocampal Neural Progenitor Cells

Oh, D. H., Lee, I. Y., Choi, M., Kim, S. H., & Son, H. (2012) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2012.16.4.281 · Cited by 17 · see citing works

Cognitive remission: a novel objective for the treatment of major depression?

Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252 · see citing works

Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force

Miskowiak, K. W., Burdick, K. E., Martínez‐Arán, A., Bonnín, C. D. M., Bowie, C. R., Carvalho, A., Gallagher, P., Lafer, B., López‐Jaramillo, C., Sumiyoshi, T., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12534 · Cited by 216 · see citing works

Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence

Rheenen, T. E. V., Lewandowski, K. E., Bauer, I. E., Kapczinski, F. P., Miskowiak, K. W., Burdick, K. E., & Balanzá‐Martínez, V. (2019) · Bipolar Disorders · doi:10.1111/bdi.12821 · Cited by 168 · see citing works

Hippocampal subfield volumes in mood disorders

Cao, B., Passos, I. C., Mwangi, B., Amaral-Silva, H., Tannous, J. D., Wu, M.-J., Zunta‐Soares, G. B., & Soares, J. C. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.262 · Cited by 166 · see citing works

Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin

Wakhloo, D., Scharkowski, F., Curto, Y., Butt, U. J., Bansal, V., Steixner-Kumar, A. A., Wüstefeld, L., Rajput, A., Arinrad, S., Zillmann, M. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15041-1 · Cited by 161 · see citing works

Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder

Bonnín, C. D. M., Reinares, M., Martínez‐Arán, A., Jiménez, E., Sánchez‐Moreno, J., Solé, B., Montejo, L., & Vieta, E. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz018 · Cited by 154 · see citing works

The Bipolar Illness Onset study: research protocol for the BIO cohort study

Kessing, L. V., Munkholm, K., Faurholt‐Jepsen, M., Miskowiak, K. W., Nielsen, L. B., Frikke‐Schmidt, R., Ekstrøm, C. T., Winther, O., Pedersen, B. K., Poulsen, H. E., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015462 · Cited by 157 · see citing works

Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders

Galvez-Contreras, A. Y., Campos-Ordonez, T., Lopez-Virgen, V., Gomez-Plascencia, J., Ramos-Zuniga, R., & Gonzalez-Perez, O. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.08.004 · Cited by 112 · see citing works

Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus

Hassouna, I. A., Ott, C., Wüstefeld, L., Offen, N., Neher, R. A., Mitkovski, M., Winkler, D., Sperling, S., Fries, L., Goebbels, S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.212 · Cited by 109 · see citing works

Hippocampal volume and verbal memory performance in late-stage bipolar disorder

Cao, B., Passos, I. C., Mwangi, B., Bauer, I. E., Zunta‐Soares, G. B., Kapczinski, F. P., & Soares, J. C. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.12.012 · Cited by 109 · see citing works

Cytokine alterations and cognitive impairment in major depressive disorder: From putative mechanisms to novel treatment targets

Misiak, B., Beszłej, J. A., Kotowicz, K., Szewczuk-Bogusławska, M., Samochowiec, J., Kucharska–Mazur, J., & Frydecka, D. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.021 · Cited by 86 · see citing works

Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression

Maller, J. J., Broadhouse, K., Rush, A. J., Gordon, E., Koslow, S., & Grieve, S. M. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.224 · Cited by 87 · see citing works

Erythropoietin as candidate for supportive treatment of severe COVID-19

Ehrenreich, H., Weißenborn, K., Begemann, M., Busch, M., Vieta, E., & Miskowiak, K. W. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00186-y · Cited by 96 · see citing works

Erythropoietin and derivatives: Potential beneficial effects on the brain

Vittori, D. C., Chamorro, M. E., Hernández, Y. V., Maltaneri, R. E., & Nesse, A. B. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15475 · Cited by 69 · see citing works

Treatment with a GLP−1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders

Mansur, R. B., Zugman, A., Ahmed, J., Cha, D. S., Subramaniapillai, M., Lee, Y. L., Lovshin, J. A., Lee, J. G., Lee, J.-H., Drobinin, V., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.08.433 · Cited by 68 · see citing works

Longitudinal relationships among depressive symptoms, cortisol, and brain atrophy in the neocortex and the hippocampus

Lebedeva, A., Sundström, A. E., Lindgren, L., Stomby, A., Aarsland, D., Westman, E., Winblad, B. G., Olsson, T., & Nyberg, L. H. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12860 · Cited by 61 · see citing works

High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial

Schreiber, K. I., Magyari, M., Sellebjerg, F. T., Iversen, P., Garde, E., Madsen, C. G., Börnsen, L. S., Christensen, J. R., Ratzer, R. L., Siebner, H. R., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516661048 · Cited by 54 · see citing works

Hippocampal neurons respond to brain activity with functional hypoxia

Butt, U. J., Steixner-Kumar, A. A., Depp, C., Sun, T., Hassouna, I. A., Wüstefeld, L., Arinrad, S., Zillmann, M. R., Schopf, N., Garcia‐Agudo, L. F., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00988-w · Cited by 53 · see citing works

Neural correlates of improved executive function following erythropoietin treatment in mood disorders

Miskowiak, K. W., Vinberg, M., Glerup, L., Paulson, O. B., Knudsen, G. M., Ehrenreich, H., Harmer, C. J., Kessing, L. V., Siebner, H. R., & Macoveanu, J. (2016) · Psychological Medicine · doi:10.1017/s0033291716000209 · Cited by 51 · see citing works

Structural changes in the hippocampus as a biomarker for cognitive improvements in neuropsychiatric disorders: A systematic review

Ott, C. V., Johnson, C. B., Macoveanu, J., & Miskowiak, K. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.01.105 · Cited by 52 · see citing works

Erythropoietin Pathway: A Potential Target for the Treatment of Depression

Ma, C., Cheng, F., Wang, X., Zhai, C., Yue, W., Lian, Y., & Wang, Q. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050677 · Cited by 51 · see citing works

The effect of erythropoietin on cognition in affective disorders – Associations with baseline deficits and change in subjective cognitive complaints

Ott, C. V., Vinberg, M., Kessing, L. V., & Miskowiak, K. W. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.05.009 · Cited by 48 · see citing works

Cognitive, emotional and social phenotyping of mice in an observer-independent setting

Dere, E., Ronnenberg, A., Tampe, B., Arinrad, S., Schmidt, M., Zeisberg, E. M., & Ehrenreich, H. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.02.023 · Cited by 37 · see citing works

Effects of erythropoietin on memory‐relevant neurocircuitry activity and recall in mood disorders

Miskowiak, K. W., Macoveanu, J., Vinberg, M., Assentoft, E., Randers, L., Harmer, C. J., Ehrenreich, H., Paulson, O. B., Knudsen, G. M., Siebner, H. R., et al. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12597 · Cited by 36 · see citing works

Norms for the Screen for Cognitive Impairment in Psychiatry and cognitive trajectories in bipolar disorder

Ott, C. V., Knorr, U. B., Jespersen, A. E., Obenhausen, K., Røen, I. S., Purdon, S. E., Kessing, L. V., & Miskowiak, K. W. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.119 · Cited by 33 · see citing works

Carbamoylated erythropoietin modulates cognitive outcomes of social defeat and differentially regulates gene expression in the dorsal and ventral hippocampus

Sathyanesan, M., Watt, M. J., Haiar, J. M., Scholl, J. L., Davies, S. R., Paulsen, R. T., Wiederin, J. L., Ciborowski, P. S., & Newton, S. S. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0168-9 · Cited by 32 · see citing works

Is cognitive dysfunction involved in difficult-to-treat depression? Characterizing resistance from a cognitive perspective

López-Solà, C., Subirà, M., Serra-Blasco, M., Vicent-Gil, M., Navarra-Ventura, G., Aguilar, E., Acebillo, S., Palao, D. J., & Cardoner, N. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2020.65 · Cited by 31 · see citing works

Structural brain abnormalities associated with cognitive impairments in bipolar disorder

Macoveanu, J., Freeman, K. O., Kjærstad, H. L., Knudsen, G. M., Kessing, L. V., & Miskowiak, K. W. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13349 · Cited by 29 · see citing works

Extensive learning is associated with gray matter changes in the right hippocampus

Koch, K., Reeß, T. J., Rus, O. G., & Zimmer, C. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.10.056 · Cited by 26 · see citing works

Contemporary blood doping—Performance, mechanism, and detection

Andersen, A. B., Nordsborg, N. B., Bonne, T. C., & Bejder, J. (2022) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.14243 · Cited by 30 · see citing works

Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review

Li, X.-B., Zheng, W., Ning, Y.-P., Cai, D.-B., Yang, X.-H., Ungvari, G. S., Ng, C. H., Wang, C., & Xiang, Y. (2017) · Pharmacopsychiatry · doi:10.1055/s-0043-114670 · Cited by 25 · see citing works

Introducing the brain erythropoietin circle to explain adaptive brain hardware upgrade and improved performance

Ehrenreich, H., Garcia‐Agudo, L. F., Steixner-Kumar, A. A., Wilke, J. B. H., & Butt, U. J. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01551-5 · Cited by 23 · see citing works

Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders? A systematic review and position paper by the International Society for Bipolar Disorders Targeting Cognition Task Force

Miskowiak, K. W., Yalın, N., Seeberg, I., Burdick, K. E., Balanzá‐Martínez, V., Bonnín, C. D. M., Bowie, C. R., Carvalho, A. F., Dols, A., Douglas, K. M., et al. (2022) · Bipolar Disorders · doi:10.1111/bdi.13247 · Cited by 23 · see citing works

Brain erythropoietin fine-tunes a counterbalance between neurodifferentiation and microglia in the adult hippocampus

Garcia‐Agudo, L. F., Steixner-Kumar, A. A., Curto, Y., Barnkothe, N., Hassouna, I. A., Jähne, S., Butt, U. J., Grewe, K., Weber, M. S., Green, K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109548 · Cited by 23 · see citing works

Subcortical Brain Volumes Relate to Neurocognition in First-Episode Schizophrenia, Bipolar Disorder, Major Depression Disorder, and Healthy Controls

Shi, J., Guo, H., Liu, S., Xue, W., Fan, F., Li, H., Fan, H., An, H., Wang, Z., Tan, S., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.747386 · Cited by 23 · see citing works

GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?

Inkster, B., Zai, G. C., Lewis, G., & Miskowiak, K. W. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0270-z · Cited by 23 · see citing works

The Effect of Recombinant Erythropoietin on Plasma Brain Derived Neurotrophic Factor Levels in Patients with Affective Disorders: A Randomised Controlled Study

Vinberg, M., Miskowiak, K. W., Højman, P., Pedersen, M., & Kessing, L. V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127629 · Cited by 23 · see citing works

Subcortical shape and neuropsychological function among U.S. service members with mild traumatic brain injury

Tate, D. F., Wade, B., Velez, C. S., Drennon, A. M., Bolzenius, J. D., Cooper, D. B., Kennedy, J. E., Reid, M., Bowles, A. O., Thompson, P. M., et al. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9854-8 · Cited by 22 · see citing works

Perimenopausal hormone therapy is associated with regional sparing of the CA1 subfield: a HUNT MRI study

Pintzka, C. W. S., & Haberg, A. K. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.05.023 · Cited by 22 · see citing works

Carbamoylated erythropoietin induces a neurotrophic gene profile in neuronal cells

Tiwari, N. K., Sathyanesan, M., Schweinle, W. E., & Newton, S. S. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.07.011 · Cited by 21 · see citing works

Delaying memory decline: different options and emerging solutions

Schneider, F., Horowitz, A., Lesch, K., & Dandekar, T. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0697-x · Cited by 21 · see citing works

Early monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression

Al‐Onaizi, M., Thériault, P., Lecordier, S., Préfontaine, P., Rivest, S., & ElAli, A. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.07.016 · Cited by 20 · see citing works

Neuronal and cognitive predictors of improved executive function following action-based cognitive remediation in patients with bipolar disorder

Miskowiak, K. W., Møller, A. B., & Ott, C. V. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.02.013 · Cited by 19 · see citing works

Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues

Begemann, M., Groß, O., Wincewicz, D., Hardeland, R., Gastaldi, V. D., Vieta, E., Weißenborn, K., Miskowiak, K. W., Moerer, O., & Ehrenreich, H. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00381-5 · Cited by 17 · see citing works

The effects of psychoeducation and motivational interviewing on treatment adherence and functionality in individuals with bipolar disorder

Harmancı, P., & Yıldız, E. (2023) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2023.04.026 · Cited by 17 · see citing works

Advances in the psychopharmacotherapy of bipolar disorder type I

Sleem, A., & El‐Mallakh, R. S. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1893306 · Cited by 16 · see citing works

Variable alterations in plasma erythropoietin and brain-derived neurotrophic factor levels in patients with major depressive disorder with and without a history of suicide attempt

Lee, B.-H., Park, Y., Hwang, J.-A., & Kim, Y. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110324 · Cited by 16 · see citing works

Towards a biomarker model for cognitive improvement: No change in memory-related prefrontal engagement following a negative cognitive remediation trial in bipolar disorder

Macoveanu, J., Demant, K. M., Vinberg, M., Siebner, H. R., Kessing, L. V., & Miskowiak, K. W. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118783334 · Cited by 16 · see citing works

Carbamoylated erythropoietin produces antidepressant-like effects in male and female mice

Sampath, D., McWhirt, J., Sathyanesan, M., & Newton, S. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109754 · Cited by 15 · see citing works

Erythropoietin Stimulates GABAergic Maturation in the Mouse Hippocampus

Khalid, K., Frei, J., Aboouf, M. A., Köster-Hegmann, C., Gassmann, M., Fritschy, J., & Gasser, E. M. S. (2021) · eNeuro · doi:10.1523/eneuro.0006-21.2021 · Cited by 15 · see citing works

Erythropoietin and Non-Erythropoietic Derivatives in Cognition

Newton, S. S., & Sathyanesan, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.728725 · Cited by 15 · see citing works

Erythropoietin re-wires cognition-associated transcriptional networks

Singh, M., Zhao, Y., Gastaldi, V. D., Wojcik, S. M., Curto, Y., Kawaguchi, R., Merino, R. M., Garcia‐Agudo, L. F., Taschenberger, H., Brose, N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40332-8 · Cited by 13 · see citing works

Baseline predictors of cognitive change in the treatment of major depressive episode: systematic review

Barczyk, Z. A., Douglas, K. M., & Porter, R. (2020) · BJPsych Open · doi:10.1192/bjo.2020.114 · Cited by 14 · see citing works

A Comparative Analysis of Erythropoietin and Carbamoylated Erythropoietin Proteome Profiles

Tiwari, N. K., Sathyanesan, M., Kumar, V., & Newton, S. S. (2021) · Life · doi:10.3390/life11040359 · Cited by 12 · see citing works

Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial

Schmidt, L. S., Petersen, J. Z., Vinberg, M., Hageman, I., Olsen, N. V., Kessing, L. V., Jørgensen, M. B., & Miskowiak, K. W. (2018) · Trials · doi:10.1186/s13063-018-2627-2 · Cited by 12 · see citing works

Association of childhood trauma with cognitive impairment and structural brain alterations in remitted patients with bipolar disorder.

Jørgensen, J. L., Macoveanu, J., Petersen, J., Knudsen, G., Kessing, L., Jørgensen, M., & Miskowiak, K. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.05.078 · Cited by 9 · see citing works

Intranasal injection of recombinant human erythropoietin improves cognitive and visual impairments in chronic cerebral ischemia rats

Zhou, Y., Sun, B., Guo, J., & Zhou, G. (2020) · Biomedical Reports · doi:10.3892/br.2020.1347 · Cited by 11 · see citing works

Effects of cognitive training under hypoxia on cognitive proficiency and neuroplasticity in remitted patients with mood disorders and healthy individuals: ALTIBRAIN study protocol for a randomized controlled trial

Miskowiak, K. W., Damgaard, V., Schandorff, J. M., Macoveanu, J., Knudsen, G. M., Johansen, A., Plavén‐Sigray, P., Svarer, C., Bruun, C. F., Cramer, K., et al. (2024) · Trials · doi:10.1186/s13063-024-08463-5 · Cited by 10 · see citing works

Impact of pretreatment interhemispheric hippocampal asymmetry on improvement in verbal learning following erythropoietin treatment in mood disorders: a randomized controlled trial

Miskowiak, K. W., Forman, J. L., Vinberg, M., Siebner, H. R., Kessing, L. V., & Macoveanu, J. (2020) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.180205 · Cited by 9 · see citing works

Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial

Miskowiak, K. W., Petersen, J. Z., Macoveanu, J., Ysbæk-Nielsen, A. T., Lindegaard, I. A., Cramer, K., Mogensen, M. B., Hammershøj, L. G., Stougaard, M. E., Jørgensen, J. L., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.12.004 · Cited by 9 · see citing works

Erythropoietin restrains the inhibitory potential of interneurons in the mouse hippocampus

Curto, Y., Carceller, H., Klimczak, P., Pérez-Rando, M., Wang, Q., Grewe, K., Kawaguchi, R., Rizzoli, S. O., Geschwind, D. H., Nave, K., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02528-2 · Cited by 8 · see citing works

Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder

Miskowiak, K. W., Petersen, N. A., Harmer, C. J., Ehrenreich, E., Kessing, L. V., Vinberg, M., Macoveanu, J., & Siebner, H. R. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12915 · Cited by 8 · see citing works

Lentiviral delivery of human erythropoietin attenuates hippocampal atrophy and improves cognition in the R6/2 mouse model of Huntington's disease

Rolfes, S., Munro, D. A. D., Lyras, E. M., Matute, E., Ouk, K., Harms, C., Böttcher, C., & Priller, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105024 · Cited by 8 · see citing works

Lack of association between erythropoietin treatment and risk of depression in patients with end-stage kidney disease on maintenance dialysis: a nationwide database study in Taiwan

Lin, P., Li, L., Wang, L., Yang, Y., & Hsu, C. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622321995690 · Cited by 6 · see citing works

EPO Deficiency Upregulates GADD45b/p38 MAPK Axis, Mediating Schizophrenia‐Related Synaptic and Cognitive Impairments

Guo, C., Li, W., Liu, Y., Tao, X., Mahaman, Y. A. R., Wang, J., Liu, R., Li, S., & Wang, X. (2024) · Advanced Science · doi:10.1002/advs.202406979 · Cited by 6 · see citing works

Erythropoietin and Erythropoietin Receptor Levels and Their Diagnostic Values in Drug-naïve Patients with Generalized Anxiety Disorder

Kurutaş, E. B. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2023.21.2.288 · Cited by 6 · see citing works

Action-based cognitive remediation in bipolar disorder improved verbal memory but had no effect on the neural response during episodic memory encoding

Macoveanu, J., Damgaard, V., Ott, C. V., Knudsen, G. M., Kessing, L. V., & Miskowiak, K. W. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111418 · Cited by 6 · see citing works

Transcriptional dynamics of the oligodendrocyte lineage and its regulation by the brain erythropoietin system

Ye, L., Gastaldi, V. D., Curto, Y., Wildenburg, A.-F., Yu, X., Hindermann, M., Eggert, S., Ronnenberg, A., Wang, Q., Butt, U. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62791-x · Cited by 5 · see citing works

Impaired allocentric spatial memory in patients with affective disorders

Hørlyck, L. D., Jespersen, A. E., King, J. A., Ullum, H., & Miskowiak, K. W. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.01.042 · Cited by 5 · see citing works

Relation Between Brain Morphological Features and Psychiatric Hospitalization Risk in Major Depressive and Bipolar Disorders

Miskowiak, K. W., Macoveanu, J., Ozenne, B., Beaman, E. E., Dam, V. H., Fisher, P. M., Knudsen, G. M., Kessing, L. V., Jørgensen, M. B., Frøkjær, V. G., et al. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13790 · Cited by 5 · see citing works

Is erythropoietin a worthy candidate for traumatic brain injury or are we heading the wrong way?

Grasso, G., Alafaci, C., & Ghezzi, P. (2016) · F1000Research · doi:10.12688/f1000research.8723.1 · Cited by 5 · see citing works

Whole-Brain Exploratory Analysis of Functional Task Response Following Erythropoietin Treatment in Mood Disorders: A Supervised Machine Learning Approach

Nielsen, S. F. V., Madsen, K. H., Vinberg, M., Kessing, L. V., Siebner, H. R., & Miskowiak, K. W. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01246 · Cited by 4 · see citing works

The effect of erythropoietin on electroconvulsive stimulation induced cognitive impairment in rats

Kjær, K. S., Jørgensen, M. B., Hageman, I., Miskowiak, K. W., & Wörtwein, G. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112484 · Cited by 4 · see citing works

Design and Development of a Behaviorally Active Recombinant Neurotrophic Factor

Pekas, N. J., Petersen, J. L., Sathyanesan, M., & Newton, S. S. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s274308 · Cited by 4 · see citing works

Acute carbamoylated erythropoietin reduces social stress-induced anxiety and depression-related behaviors

Yaeger, J. D. W., John, M. M., Ledesma, L. J., Krupp, K. T., Booth, C. D., Jones, N., Valiño, A., Popp, N., Sathyanesan, M., Newton, S. S., et al. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110558 · Cited by 3 · see citing works

Antidepressant-like effects of trophic factor receptor signaling

Sathyanesan, M., & Newton, S. S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.958797 · Cited by 3 · see citing works

Psychosocial Recovery-Oriented Treatments in Bipolar Disorders

Bonnín, C. D. M., Montejo, L., Martínez‐Arán, A., Solé, B., Comes, M., & Torrent, C. (2022) · Comprehensive approach to psychiatry · doi:10.1007/978-3-030-98301-7_11 · Cited by 3 · see citing works

Cerebrospinal fluid erythropoietin, oxidative stress, and cognitive functions in patients with bipolar disorder and healthy control participants: A longitudinal case-control study

Miskowiak, K. W., Simonsen, A. H., Meyer, M., Poulsen, H. E., Wilkan, M., Forman, J. L., Hasselbalch, S. G., Kessing, L. V., & Knorr, U. B. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.05.045 · Cited by 3 · see citing works

Chronic Kidney Disease Induces Cognitive Impairment in the Early Stage

Wang, Y., Chen, K., Qiao, Z.-X., & Bao, X.-R. (2023) · Current Medical Science · doi:10.1007/s11596-023-2783-9 · Cited by 3 · see citing works

Synergism of Carbamoylated Erythropoietin and Insulin-like Growth Factor-1 in Immediate Early Gene Expression

Rothschadl, M. J., Sathyanesan, M., & Newton, S. S. (2023) · Life · doi:10.3390/life13091826 · Cited by 2 · see citing works

Erythropoietin as an Innovative Add-on Therapy for Depression

Falkai, P., & Schmitt, A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.003 · Cited by 2 · see citing works

Treatment opportunities for ameliorating cognitive dysfunction in major depressive disorder

Cha, D. S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139860567.019 · Cited by 2 · see citing works

Could EPO studies improve mood disorder treatment strategies?

Miskowiak, K. W. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1272412 · Cited by 2 · see citing works

Insights, challenges and new frontiers for cognitive function in bipolar disorder

Miskowiak, K. W., Kjærstad, H. L., Vieta, E., & Yatham, L. N. (2026) · Nature Mental Health · doi:10.1038/s44220-026-00615-7 · Cited by 1 · see citing works

Hippocampal volume changes in patients with mood disorders

Santos, M. A. O., Bezerra, L. S., Carvalho, A. R. M. R., & Lima, A. C. M. B. D. Q. (2018) · International Journal of Radiology & Radiation Therapy · doi:10.15406/ijrrt.2018.05.00159 · Cited by 1 · see citing works

The history of Danish neuroscience

Paulson, O. B., Schousboe, A., & Hultborn, H. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16062 · Cited by 1 · see citing works

Genes Encoding Erythropoietin and Its Receptor in Bipolar I (Manic Phase) Patients as a Novel Diagnostic Agent: A Case-Control Study

Moradi, M., Saidijam, M., Ghaleiha, A., Jahangard, L., Yadegarazari, R., & Keshavarzi, A. (2019) · Neurochemical Journal · doi:10.1134/s1819712419020089 · Cited by 1 · see citing works

A novel treatment targeting cognitive dysfunction in mood disorders

Miskowiak, K. W. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139860567.021

Erythropoietin as a driver of neurodifferentiation, neuroplasticity and cognition – A continuum view of the neuronal lineage

Wakhloo, D. (2019) · doi:10.53846/goediss-7758

Zur Rolle des homodimeren Erythropoietin-Rezeptors für erythropoietininduzierte Neurogenese und kognitive Funktionen im Mausmodell

Zillmann, M. R. (2022) · doi:10.53846/goediss-9290

Transcriptional networks predating cognition-associated pyramidal lineages are restructured by erythropoietinPreprint

Singh, M., Zhao, Y., Gastaldi, V. D., Wojcik, S. M., Curto, Y., Kawaguchi, R., Merino, R. M., Garcia-Agudo, L. F., Taschenberger, H., Brose, N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.04.527116

The Management of Neurocognitive Impairment in Mood Disorders

Gallagher, P., & Young, A. H. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108973922.023

Exploring the effects of erythropoietin treatment on cortical thickness and hippocampal volume in patients with mood disorders undergoing electroconvulsive therapy: A randomized, placebo-controlled trial

Macoveanu, J., Petersen, J. Z., Vinberg, M., Brendstrup‐Brix, K., Kessing, L. V., Jørgensen, M. B., & Miskowiak, K. W. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241301224

Effects of Carbamylated Darbepoetin on Mitochondrial Contacts in Primary Neuronal Cultures

Shirokova, O. M., Sokolov, R. A., Pershin, V. I., Guseva, M. S., & Mukhina, I. V. (2025) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747824700521

Multivariate associations between structural brain changes and cognitive impairment in partially or fully remitted persons with bipolar disorder

Schandorff, J. M., Madsen, A. B. F., Damgaard, V., Little, B., Sankar, A., Macoveanu, J., Frøkjær, V. G., Kessing, L. V., Jørgensen, M. B., Knudsen, G. M., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111425

Élaboration d’un programme de remédiation cognitive au profit des patients bipolaires : approche clinique et neuropsychologique

Isaac, C. (2018) · theses.fr (ABES) · doi:10.70675/76f0e456zbbffz46edzad9bza7fe3f88440a

From Erythropoiesis to Circuit Rewiring: Erythropoietin as a Precision Tool for Neurorestoration

Almaguer‐Melian, W., Mercerón‐Martínez, D., Acosta, B. B., & Bergado, J. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104329

Abus, mésusages et détournements des psychotropes : évolution récente et perspective

Coquerel, A. (2026) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2026.05.016

Exploring Associations Between Hypoxia, Serum Erythropoietin, and Cognition in Patients With Mood Disorders and Healthy Individuals

Orum, B. E. R., Schandorff, J. M., Damgaard, V., Rødgaard, E., Bruun, C. F., Meyer, M., Kessing, L. V., Jørgensen, M. B., & Miskowiak, K. W. (2026) · Brain and Behavior · doi:10.1002/brb3.71812

Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression

Miskowiak, K. W., Vinberg, M., Harmer, C. J., Ehrenreich, H., & Kessing, L. V. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2511-1 · Cited by 70 · see citing works

Effects of erythropoietin on memory‐relevant neurocircuitry activity and recall in mood disorders

Miskowiak, K. W., Macoveanu, J., Vinberg, M., Assentoft, E., Randers, L., Harmer, C. J., Ehrenreich, H., Paulson, O. B., Knudsen, G. M., Siebner, H. R., et al. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12597 · Cited by 36 · see citing works

Neural correlates of improved executive function following erythropoietin treatment in mood disorders

Miskowiak, K. W., Vinberg, M., Glerup, L., Paulson, O. B., Knudsen, G. M., Ehrenreich, H., Harmer, C. J., Kessing, L. V., Siebner, H. R., & Macoveanu, J. (2016) · Psychological Medicine · doi:10.1017/s0033291716000209 · Cited by 51 · see citing works

The effects of erythropoietin on cognitive and neurobiological function in healthy and depressed subjects

Miskowiak, K. W. (2007) · OpenGrey (Institut de l'Information Scientifique et Technique)

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder

Miskowiak, K. W., Vinberg, M., Harmer, C. J., Ehrenreich, H., Knudsen, G. M., Macoveanu, J., Hansen, A. R. E., Paulson, O. B., Siebner, H. R., & Kessing, L. V. (2010) · Trials · doi:10.1186/1745-6215-11-97 · Cited by 51 · see citing works